| 02-05-2012 03:00 PM CET - Politics, Law & Society |
|
GlaxoSmithKline Agrees to Settlement in 20,000 Avandia Lawsuits
Press release from: Nadrich & Cohen LLP
(openPR) - Nadrich & Cohen, LLP reports that GlaxoSmithKline has agreed to settle approximately 20,000 Avandia side effects lawsuits.
Los Angeles, CA, February 3, 2012 – UK drug-maker GlaxoSmithKline has agreed to settle 20,000 Avandia side effects lawsuits. According to a Bloomberg report, the company previously agreed to pay at least $700 million to settle more than 15,000 claims on behalf of patients who said that the drug caused heart attacks, strokes and other complications.
Avandia (rosiglitazone) was first approved by the FDA in 1999 to treat Type 2 diabetes in adult patients. The drug hit the market the same year as another popular diabetes drug, Actos (pioglitazone). The maker of Actos, Takeda Pharmaceuticals, is now facing numerous lawsuits from patients who claim the drug caused them to develop bladder cancer.
GlaxoSmithKline announced in November 2011 that it would $3 billion to the federal government in connection with claims that the company had illegally marketed Avandia. In addition to the 20,000 cases involved in the settlement agreement, Avandia side effects claims are still pending in state courts across the country. An estimated 2,500 federal lawsuits that were consolidated in a Philadelphia court have also been assigned to mediation.
Patients who experienced complications after using Avandia are encouraged to complete a MedWatch form by visiting the FDA’s website. Patients are also urged to seek the aid of an experienced personal injury lawyer to discuss their legal rights.
Nadrich & Cohen LLP is offering confidential, no-cost consultations to individuals across the country who believe they were harmed by Avandia. Help is available by calling the firm’s injury hotline at 1-800-718-4658.
Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California specializing in handling mass tort actions and representing individuals in cases involving pharmaceutical companies and medical device manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.
In addition to handling Avandia side effects claims, the firm is also investigating cases involving Accutane, Actos, Zoloft, Fosamax, Paxil, Vaginal Mesh, Wright Conserve Hips, Yaz, Yasmin, Stevens-Johnson Syndrome, Benzene, Reflex Sympathy Dystrophy, Fen Phen and PPH, Depakote and Reglan. For more information, visit www.personalinjurylawcal.com.
Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com
www.personalinjurylawcal.com
Los Angeles, CA, February 3, 2012 – UK drug-maker GlaxoSmithKline has agreed to settle 20,000 Avandia side effects lawsuits. According to a Bloomberg report, the company previously agreed to pay at least $700 million to settle more than 15,000 claims on behalf of patients who said that the drug caused heart attacks, strokes and other complications.
Avandia (rosiglitazone) was first approved by the FDA in 1999 to treat Type 2 diabetes in adult patients. The drug hit the market the same year as another popular diabetes drug, Actos (pioglitazone). The maker of Actos, Takeda Pharmaceuticals, is now facing numerous lawsuits from patients who claim the drug caused them to develop bladder cancer.
GlaxoSmithKline announced in November 2011 that it would $3 billion to the federal government in connection with claims that the company had illegally marketed Avandia. In addition to the 20,000 cases involved in the settlement agreement, Avandia side effects claims are still pending in state courts across the country. An estimated 2,500 federal lawsuits that were consolidated in a Philadelphia court have also been assigned to mediation.
Patients who experienced complications after using Avandia are encouraged to complete a MedWatch form by visiting the FDA’s website. Patients are also urged to seek the aid of an experienced personal injury lawyer to discuss their legal rights.
Nadrich & Cohen LLP is offering confidential, no-cost consultations to individuals across the country who believe they were harmed by Avandia. Help is available by calling the firm’s injury hotline at 1-800-718-4658.
Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California specializing in handling mass tort actions and representing individuals in cases involving pharmaceutical companies and medical device manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.
In addition to handling Avandia side effects claims, the firm is also investigating cases involving Accutane, Actos, Zoloft, Fosamax, Paxil, Vaginal Mesh, Wright Conserve Hips, Yaz, Yasmin, Stevens-Johnson Syndrome, Benzene, Reflex Sympathy Dystrophy, Fen Phen and PPH, Depakote and Reglan. For more information, visit www.personalinjurylawcal.com.
Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com
www.personalinjurylawcal.com
News-ID: 209672
More releases
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
© openPR 2012 | Imprint
More Releases from
Nadrich & Cohen LLP
Comments about openPR
9 o'clock: discuss press release with client
10 o'clock: submit release to openPR
Within the briefest possible time release is published and displayed in a prominent place on openPR.de. I am thrilled!
Zehra Spindler, Calypso Now! - Communication Agency
10 o'clock: submit release to openPR
Within the briefest possible time release is published and displayed in a prominent place on openPR.de. I am thrilled!
Zehra Spindler, Calypso Now! - Communication Agency

